Elanco Sees Strong Pet Health Momentum, Bets on Innovative Products
Elanco Animal Health Incorporated (NYSE: ELAN ) delivered strong financial performance for the second quarter of 2026, driven by robust demand across its Pet Health portfolio and expanding margins. The momentum led management to raise its full-year growth outlook. The pet health company reported adjusted earnings of 34